Semaglutide studies: 1,194 papers with results
Page 8 of 24
- The Weight-loss Effect of GLP-1RAs Glucagon-Like Peptide-1 Receptor Agonists in Non-diabetic Individuals with Overweight or Obesity: A Systematic Review with Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Trials.
Liu Y · The American journal of clinical nutrition · 2023
Systematic review · 9 results
- Efficacy and safety of GLP-1 receptor agonists versus SGLT-2 inhibitors in overweight/obese patients with or without diabetes mellitus: a systematic review and network meta-analysis.
Ma H · BMJ open · 2023
Systematic review · 12 results
- Clinical Pharmacokinetics of Semaglutide: A Systematic Review.
Yang XD · Drug design, development and therapy · 2024
Systematic review · 5 results
- Effects of Antidiabetic Drugs on Muscle Mass in Type 2 Diabetes Mellitus.
Ida S · Current diabetes reviews · 2021
Systematic review · 2 results
- Sex Differences in the Efficacy of Glucagon-Like Peptide-1 Receptor Agonists for Weight Reduction: A Systematic Review and Meta-Analysis.
Yang Y · Journal of diabetes · 2025
Systematic review · 6 results
- Efficacy and tolerability of sodium-glucose co-transporter-2 inhibitors and glucagon-like peptide-1 receptor agonists: A systematic review and network meta-analysis.
Hussein H · Diabetes, obesity & metabolism · 2020
Systematic review · 11 results
- Anti-obesity pharmacological agents for polycystic ovary syndrome: A systematic review and meta-analysis to inform the 2023 international evidence-based guideline.
Goldberg A · Obesity reviews : an official journal of the International Association for the Study of Obesity · 2024
Systematic review · 2 results
- Risk of Malignant Neoplasia with Glucagon-Like Peptide-1 Receptor Agonist Treatment in Patients with Type 2 Diabetes: A Meta-Analysis.
Liu Y · Journal of diabetes research · 2019
Systematic review · 6 results
- Gastrointestinal adverse events associated with GLP-1 RA in non-diabetic patients with overweight or obesity: a systematic review and network meta-analysis.
Ismaiel A · International journal of obesity (2005) · 2025
Systematic review · 19 results
- The Antiobesity Effect and Safety of GLP-1 Receptor Agonist in Overweight/Obese Patients Without Diabetes: A Systematic Review and Meta-Analysis.
Guo X · Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme · 2022
Systematic review · 14 results
- Comparison of the efficacy and safety of 10 glucagon-like peptide-1 receptor agonists as add-on to metformin in patients with type 2 diabetes: a systematic review.
Xie Z · Frontiers in endocrinology · 2023
Systematic review · 15 results
- Effects of GLP-1 receptor agonists on neurological complications of diabetes.
García-Casares N · Reviews in endocrine & metabolic disorders · 2023
Systematic review · 6 results
- Comparison of the effects of 10 GLP-1 RA and SGLT2 inhibitor interventions on cardiovascular, mortality, and kidney outcomes in type 2 diabetes: A network meta-analysis of large randomized trials.
Wei XB · Primary care diabetes · 2021
Systematic review · 1 result
- Efficacy and safety of the glucagon-like peptide-1 receptor agonist oral semaglutide in patients with type 2 diabetes mellitus: A systematic review and meta-analysis.
Li J · Diabetes research and clinical practice · 2021
Systematic review · 20 results
- Comprehensive analysis of the safety of semaglutide in type 2 diabetes: a meta-analysis of the SUSTAIN and PIONEER trials.
Yin DG · Endocrine journal · 2021
Systematic review · 5 results
- Indirect comparison of glucagon like peptide-1 receptor agonists regarding cardiovascular safety and mortality in patients with type 2 diabetes mellitus: network meta-analysis.
Alfayez OM · Cardiovascular diabetology · 2020
Systematic review · 11 results
- Comparative gastrointestinal adverse effects of GLP-1 receptor agonists and multi-target analogs in type 2 diabetes: a Bayesian network meta-analysis.
Xie X · Frontiers in pharmacology · 2025
Systematic review · 9 results
- A Review and Meta-Analysis of the Safety and Efficacy of Using Glucagon-like Peptide-1 Receptor Agonists.
Hu EH · Medicina (Kaunas, Lithuania) · 2024
Systematic review · 14 results
- Semaglutide for the treatment of type 2 Diabetes Mellitus: A systematic review and network meta-analysis of safety and efficacy outcomes.
Zaazouee MS · Diabetes & metabolic syndrome · 2022
Systematic review · 8 results
- Efficacy of GLP-1-based Therapies on Metabolic Dysfunction-associated Steatotic Liver Disease and Metabolic Dysfunction-associated Steatohepatitis: A Systematic Review and Meta-analysis.
Wang Y · The Journal of clinical endocrinology and metabolism · 2025
Systematic review · 32 results
- Efficacy and safety of GLP-1RAs for people with obesity: A systematic review based on RCT and Bayesian network meta-analysis.
Li H · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2024
Systematic review · 7 results
- Efficacy of Off-Label Therapy for Non-alcoholic Fatty Liver Disease in Improving Non-invasive and Invasive Biomarkers: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.
Luo Q · Frontiers in medicine · 2022
Systematic review · 18 results
- Comparative efficacy of 5 sodium glucose cotransporter 2 inhibitor and 7 glucagon-like peptide 1 receptor agonists interventions on cardiorenal outcomes in type 2 diabetes patients: A network meta-analysis based on cardiovascular or renal outcome trials.
Duan XY · Medicine · 2021
Systematic review · 9 results
- Glucagon-Like Peptide-1 Receptor Agonists Improve MASH and Liver Fibrosis: A Meta-Analysis of Randomised Controlled Trials.
Mantovani A · Liver international : official journal of the International Association for the Study of the Liver · 2025
Systematic review · 5 results
- Comparison of the efficacy and safety of GLP-1 receptor agonists on cardiovascular events and risk factors: A review and network meta-analysis.
An X · Diabetes, obesity & metabolism · 2025
Systematic review · 14 results
- Evaluation and comparison of efficacy and safety of tirzepatide and semaglutide in patients with type 2 diabetes mellitus: A Bayesian network meta-analysis.
Ding Y · Pharmacological research · 2024
Systematic review · 48 results
- Clinical outcomes associated with drugs for obesity and overweight: A systematic review and network meta-analysis of randomized controlled trials.
Iannone A · Diabetes, obesity & metabolism · 2023
Systematic review · 6 results
- A systematic review on the role of glucagon-like peptide-1 receptor agonists on alcohol-related behaviors: potential therapeutic strategy for alcohol use disorder.
Zheng YJ · Acta neuropsychiatrica · 2025
Systematic review · 3 results
- Safety and efficacy of glucagon-like peptide-1 (GLP-1) receptor agonists in patients with weight regain or insufficient weight loss after metabolic bariatric surgery: A systematic review and meta-analysis.
Esparham A · Obesity reviews : an official journal of the International Association for the Study of Obesity · 2024
Systematic review · 7 results
- The effect of glucagon-like Peptide-1 receptor agonists on measures of suicidality: A systematic review.
Valentino K · Journal of psychiatric research · 2025
Systematic review · 8 results
- Weight loss with subcutaneous semaglutide versus other glucagon-like peptide 1 receptor agonists in type 2 diabetes: a systematic review.
Stretton B · Internal medicine journal · 2023
Systematic review · 4 results
- Is it Time to Expand Glucagon-like Peptide-1 Receptor Agonist Use for Weight Loss in Patients Without Diabetes?
Updike WH · Drugs · 2021
Systematic review · 10 results
- Efficacy of GLP-1 Receptor Agonist-Based Therapies on Cardiovascular Events and Cardiometabolic Parameters in Obese Individuals Without Diabetes: A Meta-Analysis of Randomized Controlled Trials.
Yin Y · Journal of diabetes · 2025
Systematic review · 14 results
- Effect of tirzepatide on glycaemic control and weight loss compared with other glucagon-like peptide-1 receptor agonists in Japanese patients with type 2 diabetes mellitus.
Tsukamoto S · Diabetes, obesity & metabolism · 2024
Systematic review · 7 results
- Glucagon-like peptide-1 receptor agonists in adolescents with overweight or obesity with or without type 2 diabetes multimorbidity-a systematic review and network meta-analysis.
Shamim MA · Diabetes, obesity & metabolism · 2024
Systematic review · 6 results
- Glucagon-like peptide 1-receptor agonists and A1c: Good for the heart but less so for the eyes?
Albert SG · Diabetes & metabolic syndrome · 2023
Systematic review · 9 results
- Intentional weight loss in overweight and obese patients with heart failure: A systematic review.
Peck KH · European journal of heart failure · 2024
Systematic review · 2 results
- An Indirect Treatment Comparison of Semaglutide 2.0 mg vs Dulaglutide 3.0 mg and 4.5 mg Using Multilevel Network Meta-regression.
Lingvay I · The Journal of clinical endocrinology and metabolism · 2022
Systematic review · 6 results
- Pharmacological interventions for addressing pediatric and adolescent obesity: A systematic review and network meta-analysis.
Yang S · PloS one · 2025
Systematic review · 5 results
- Comparing the effectiveness of long-term use of daily and weekly glucagon-like peptide-1 receptor agonists treatments in patients with nonalcoholic fatty liver disease and type 2 diabetes mellitus: a network meta-analysis.
Yuan X · Frontiers in endocrinology · 2023
Systematic review · 11 results
- Efficacy and safety of oral semaglutide in type 2 diabetes: A systematic review of real-world evidence.
Singh AK · Diabetes & metabolic syndrome · 2024
Systematic review · 10 results
- GLP-1 receptor agonists as an adjunct to bariatric surgery for weight loss and metabolic outcome improvement: a systematic review and meta-analysis.
Tan YW · Langenbeck's archives of surgery · 2025
Systematic review · 13 results
- Efficacy and safety of GLP-1 agonists in the treatment of T2DM: A systematic review and network meta-analysis.
Ren X · Scientific reports · 2025
Systematic review · 29 results
- Comparative effectiveness of semaglutide versus liraglutide, dulaglutide or tirzepatide: a systematic review and meta-analysis.
Karimi MA · Frontiers in pharmacology · 2025
Systematic review · 26 results
- GLP-1 receptor agonists for weight loss: A systematic review and meta-analysis of randomized controlled trials.
Ahmad N · Medicine · 2026
Systematic review · 4 results
- Glucagon-like peptide-1 receptor agonist treatment reduces body weight and improves glycaemic outcomes in patients with concurrent overweight/obesity and type 1 diabetes: A systematic review and meta-analysis.
Purcell AR · Diabetes, obesity & metabolism · 2026
Systematic review · 10 results
- Effectiveness of pharmacological interventions for managing obesity in children and adolescents: A systematic review and meta-analysis framed using minimal important difference estimates based on GRADE guidance to inform a clinical practice guideline.
Wahi G · Pediatric obesity · 2024
Systematic review · 10 results
- Once-Weekly Semaglutide Versus Once-Daily Liraglutide for Weight Loss in Adults: A Meta-Analysis of Randomized Controlled Trials.
Hashmi TM · Clinical and translational science · 2025
Systematic review · 10 results
- Semaglutide and heart failure: Updated meta-analysis.
Barbagelata L · Current problems in cardiology · 2024
Systematic review · 1 result
- Side effect profile of pharmacologic therapies for liver fibrosis in nonalcoholic fatty liver disease: a systematic review and network meta-analysis.
Li Y · European journal of gastroenterology & hepatology · 2023
Systematic review · 3 results